Dr Reddys Laboratories (RDY) Gross Margin Growth (3y) (2012 - 2023)
Dr Reddys Laboratories (RDY) Gross Margin Growth (3y) (2012 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 567.00 |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | -100.00 |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 59.00 |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | -196.00 |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -228.00 |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 12.00 |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | -61.00 |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Alkermes | 8.07 Bn | 7.41 Bn | 397.90 Mn | -954.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 475.00 |
| Mar 31, 2023 | 262.00 |
| Sep 30, 2022 | 515.00 |
| Jun 30, 2021 | -155.00 |
| Mar 31, 2021 | -341.00 |
| Sep 30, 2020 | -246.00 |
| Sep 30, 2019 | -535.00 |
| Mar 31, 2019 | -939.00 |
| Dec 31, 2018 | -264.00 |
| Sep 30, 2018 | -557.00 |
| Jun 30, 2018 | -645.00 |
| Dec 31, 2017 | -142.00 |
| Sep 30, 2017 | -196.00 |
| Dec 31, 2016 | -59.00 |
| Sep 30, 2016 | -100.00 |
| Mar 31, 2016 | 6,199.00 |
| Dec 31, 2015 | 456.00 |
| Sep 30, 2015 | 158.00 |
| Jun 30, 2015 | 117.00 |
| Dec 31, 2014 | 236.00 |